Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NBM BMX softgel capsules - NatureWise Biotech & Medicals

Drug Profile

NBM BMX softgel capsules - NatureWise Biotech & Medicals

Alternative Names: NBM-BMX; NBM-BMX oral softgel capsules

Latest Information Update: 22 Jan 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator NatureWise Biotech & Medicals Corporation
  • Class Antidementias; Antineoplastics; Small molecules
  • Mechanism of Action HDAC8 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Solid tumours
  • Preclinical Alzheimer's disease

Most Recent Events

  • 18 Jan 2019 Phase-I clinical trials in Solid tumours (Late-stage disease, Inoperable/Unresectable, Refractory metastatic disease, Second-line therapy or greater) in Taiwan (PO) (NCT03808870)
  • 09 Nov 2018 Preclinical trials in Alzheimer's disease in Taiwan (PO) (NatureWise Biotech & Medicals pipeline, November 2018)
  • 09 Nov 2018 NatureWise Biotech & Medicals announces intention to submit IND to for Alzheimer's disease in Q3 of 2020 (NatureWise Biotech & Medicals pipeline, November 2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top